Skip to main content
Displaying 1 - 12 of 32
Display:
12
24
48
Immune-Mediated and Cholestatic Diseases
GSK: "Investigating IBAT inhibition in itch – a new tool for an age-old problem?" (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
GSK: "Practical tips towards providing holistic care to patients with PBC" (Complete Session)
Webcasts
View
Viral Hepatitis
GSK: “Looking to the future of hepatitis B: how can we achieve functional cure?” (Complete Session)
Webcasts
View
Viral Hepatitis
GSK: "Looking To The Future Of Hepatitis B: An Expert Review Of Quantitative Hepatitis B Surface Antigen Assessment” (Complete...
Webcasts
View
Metabolism, Alcohol & Toxicity
Welcome and introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
Tools for early detection of metabolic risk in MAFLD
Webcasts
View
Metabolism, Alcohol & Toxicity
Insights from the SIRIUS project – a population-wide liver disease screening program in Slovakia
Webcasts
View
Metabolism, Alcohol & Toxicity
Early screening of metabolic risk – the pharmacists’ perspective
Webcasts
View
Metabolism, Alcohol & Toxicity
Summary and closing remarks
Webcasts
View
Metabolism, Alcohol & Toxicity
Sanofi: "Global Liver Health Forum 2023" (Complete Session)
Webcasts
View
Metabolism, Alcohol & Toxicity
Welcome and introduction
Webcasts
View
Metabolism, Alcohol & Toxicity
To what extent can HRQoL impact clinical outcomes in MAFLD?
Webcasts
View
Pagination
Current page
1
Page
2
Page
3
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy